Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Owen, M. J
Right arrow Articles by Crumpton, M. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Owen, M. J
Right arrow Articles by Crumpton, M. J
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 43:228-240 (1987)
© 1987 The British Council

research-article

The role of Class I and II antigens in T cell recognition

Michael J Owen and Michael J Crumpton

Tumour Immunology Unit, Imperial Cancer Research Fund, University College London London
Imperial Cancer Research Fund, Lincoln's Inn Fields London

Abstract

T and B lymphocytes each exhibit a large number of specificities in respect of the recognition of antigen that are clonally inherited. They differ, however, in that T cells recognise cell bound antigen in association with a gene product of the major histocompatibility complex (the principle of MHC restriction) whereas recognition by B cells is generally MHC unrestricted. Thus, the modern concept of class I and II antigen function is that they act as guidance systems for T cells. Two basic models, involving one or two binding sites for antigen and MHC product, have been proposed to account for MHC-restricted recognition of antigen by T cells. Several lines of evidence, including detailed analysis of the structure of the T cell receptor, favour the one receptor model. This receptor (when expressed on the surface of a T ‘killer’ cell) apparently recognises the two N-terminal domains of class I antigens and, at least in some cases, processed antigen in the form of peptide fragments.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.